產(chǎn)品名稱 |
SFR3-DR5 |
商品貨號 |
B165684 |
Organism |
Rattus norvegicus (B cell); Mus musculus (myeloma), rat (B cell); mouse (myeloma) |
Cell Type |
hybridoma: B lymphocyte |
Product Format |
frozen |
Morphology |
lymphoblast |
Culture Properties |
suspension |
Biosafety Level |
1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
Strain |
Strain:? KGH (B cell); BALB/c (myeloma) |
Applications |
Tested and found negative for ectromelia virus (mousepox). |
Derivation |
Animals were immunized with purified DR antigen from obtained from the Swei human lymphoblastoid cell line. Popliteal lymph node cells were fused with Sp2/0-Ag14 myeloma cells. |
Genes Expressed |
immunoglobulin; monoclonal antibody; against HLA DR5 |
Cellular Products |
immunoglobulin; monoclonal antibody; against HLA DR5 |
Comments |
Animals were immunized with purified DR antigen from obtained from the Swei human lymphoblastoid cell line. Popliteal lymph node cells were fused with Sp2/0-Ag14 myeloma cells. Tested and found negative for ectromelia virus (mousepox). |
Complete Growth Medium |
The base medium for this cell line is ATCC-formulated Dulbecco's Modified Eagle's Medium, Catalog No. 30-2002. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 10%.
|
Subculturing |
Medium Renewal: Every 2 to 3 days Cultures can be maintained by addition or replacement of fresh medium. Start cultures at 2 X 10 exp5 cells/ml and maintain between 1 X 10 exp5 and 1 X 10 exp6 cells/ml. |
Cryopreservation |
culture medium 95%; DMSO, 5% |
Culture Conditions |
Temperature: 37.0°C |
Isotype |
IgG2b |
Name of Depositor |
SF Radka |
Deposited As |
rat (B cell); mouse (myeloma) |
References |
Radka SF, et al. SFR3-DR5, a monoclonal antibody with HLA-DR5 specificity. J. Immunol. 130: 1863-1866, 1983. PubMed: 6187822
|